Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Attenuated Salmonella Typhimurium (Attenuated S. Typhimurium)
- Target
- Attenuated S. Typhimurium
- Molecular classification
- Bacterium, Vaccine vector, Therapeutic delivery vehicle
01
Overview
Attenuated Salmonella Typhimurium refers to genetically or metabolically modified strains of Salmonella enterica serovar Typhimurium with reduced virulence. These strains are engineered for use as live vaccine vectors and therapeutic delivery vehicles, particularly in cancer therapy. Attenuation is achieved through deletion or mutation of genes essential for virulence, metabolism, or intracellular survival, while retaining the ability to stimulate a robust immune response. Safety considerations involve balancing sufficient attenuation to prevent disease with retained immunogenicity for effective protection or therapy.
- Other names
- Attenuated Salmonella enterica serovar TyphimuriumGenetically modified Salmonella TyphimuriumLive attenuated Salmonella Typhimurium
02
Mechanism of action
Induction of humoral and cellular immunity; targeted delivery of therapeutic agents to tumors.
03
Biological functions
Immune stimulationAntigen deliveryTumor targeting
04
Disease associations
Infectious disease (vaccine target)Cancer (therapeutic agent)
05
Safety considerations
Risk of incomplete attenuation leading to diseasePotential for prolonged sheddingUnpredictable effects of specific genetic modificationsAdequate immunogenicity vs. safety balance
Beyond the preview
Go deeper on Attenuated Salmonella Typhimurium (Attenuated S. Typhimurium).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Attenuated Salmonella Typhimurium (Attenuated S. Typhimurium).